SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Brain Scientific Inc. (BRSF) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 21/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
17/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BRSF
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-12.95
每股账面价值$0.00
每股营收$0.23
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2015 |
$0.00 |
$0.00 |
$-50.00 |
- |
| 2016 |
$-0.78 |
$0.00 |
$-90.73K |
- |
| 2017 |
$-6.65 |
$7.02K |
$-958.28K |
-13646.9% |
| 2018 |
$-9.72 |
$58.11K |
$-1.43M |
-2454% |
| 2019 |
$-4.44 |
$489.2K |
$-1M |
-205.2% |
| 2020 |
$-8.88 |
$93.66K |
$-2.8M |
-2992.6% |
| 2021 |
$-27.07 |
$265.75K |
$-9.77M |
-3677.1% |
| 2022 |
$-12.95 |
$214.56K |
$-12.34M |
-5753% |
